| | Antimicrobial Resistance: A Deadly Burden No Country Can |
| | 0,36 | | MB | Afford to Ignore |
| | 52 | | stron |
| | 5659 | | ID | Canadian Committee on Antibiotic Resistance |
| | 2007 | | rok |
| | Table of Contents |
| | I. Executive Summary. 1 |
| | II. Introduction 4 |
| | III. Background: The Evolving Situation Confronting Us 7 |
| | A Call to Action in Canada . 7 |
| | Antibiotic-Resistant Organisms in Canada . 8 |
| | Measuring a Moving Target 9 |
| | Implications of Bioterrorism. 9 |
| | Implications of Litigation, Premature Death, Wrongful Death and Equity 11 |
| | Health Canada’s Call to Action Acknowledged . 11 |
| | IV. Estimated Economic and Social Burden of Illness in Canada 13 |
| | A. Increased Cost of Providing Care to Infected Individuals . 13 |
| | B. Infrastructure Costs Of Maintaining Surveillance Programs And Reference Laboratory Services. |
| | 16 |
| | C. Diminished Quality Of Life 18 |
| | V. Implications for Investments Required 26 |
| | VI. References: 30 |
| | VII. Appendices 36 |
| | Appendix A: The Markov Model 36 |
| | Appendix B: Cost Details 39 |
| | Appendix C: Interview Scripts 40 |
| | 1) Patient Script. 40 |
| | 2) Health-care Provider Script. 44 |
| | Appendix D: Integrated Action Plan Recommendations from 1997 conference 47 |